Is venetoclax the new backbone of acute myeloid leukaemia therapy?

被引：0
|
作者：
Jain, Prachi [1 ]
Mims, Alice S. [1 ]
机构：
[1] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA
来源：
LANCET HAEMATOLOGY | 2021年 / 8卷 / 08期
关键词：
CYTARABINE; CLADRIBINE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E536 / E537
页数：2
相关论文
共 50 条
  • [1] Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
    Nwosu, Gus O.
    Ross, David M.
    Powell, Jason A.
    Pitson, Stuart M.
    CELL DEATH & DISEASE, 2024, 15 (06):
  • [2] Venetoclax and acute myeloid leukaemia: an expanding new frontier Comment
    Sahasrabudhe, Kieran D.
    Mims, Alice S.
    LANCET HAEMATOLOGY, 2022, 9 (06): : E387 - E389
  • [3] Venetoclax for paediatric acute myeloid leukaemia: a step forward
    Aplenc, Richard
    LANCET ONCOLOGY, 2020, 21 (04): : 476 - 478
  • [4] New potential therapy targets in acute myeloid leukaemia
    Gallo, A.
    Bund, D.
    Mindnich, R.
    Buhmann, R.
    Schmetzer, H.
    Adamski, J.
    Kolb, H.
    EXPERIMENTAL HEMATOLOGY, 2007, 35 (09) : 64 - 64
  • [5] Pityriasiform drug eruption associated with venetoclax for acute myeloid leukaemia
    Liu, Timothy J.
    McMeniman, Erin K.
    ANTI-CANCER DRUGS, 2024, 35 (07) : 641 - 643
  • [6] Venetoclax with intensive chemotherapy in younger patients with acute myeloid leukaemia
    Juliusson, Gunnar
    LANCET HAEMATOLOGY, 2022, 9 (05): : E317 - E318
  • [7] Single low-dose decitabine as frontline therapy of acute myeloid leukaemia, with venetoclax salvage
    Jitaru, Ciprian
    Peters, Mareike Cathrina
    Aggarwal, Lovisha
    Bancos, Anamaria
    Tigu, Adrian Bogdan
    Cenariu, Diana
    Selicean, Cristina
    Pasca, Sergiu
    Moisoiu, Vlad
    Rotariu, Petra
    Santa, Maria
    Iluta, Sabina
    Drula, Rares
    Kegyes, David
    Kurtus, Aranka
    Zdrenghea, Mihnea
    Gondek, Lukasz
    Tomuleasa, Ciprian
    Ghiaur, Gabriel
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (20)
  • [8] Venetoclax combination therapy with hypomethylating agents in young adults with relapsed/refractory acute myeloid leukaemia
    Baez-Gutierrez, Nerea
    Rodriguez-Ramallo, Hector
    Antonia-Perez Moreno, Maria
    Arboli, Eduardo-Rodriguez
    Abdel-Kader Martin, Laila
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [9] microRNA expression in acute myeloid leukaemia: New targets for therapy?
    Fletcher, Daniel
    Brown, Elliott
    Javadala, Julliah
    Uysal-Onganer, Pinar
    Guinn, Barbara-ann
    EJHAEM, 2022, 3 (03): : 596 - 608
  • [10] Venetoclax resistance in acute myeloid leukaemia-Clinical and biological insights
    Nachmias, Boaz
    Aumann, Shlomzion
    Haran, Arnon
    Schimmer, Aaron D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (04) : 1146 - 1158
12345